Although the numbers of specimens analyzed in the present data are relatively small, the findings do show that there is a significant trend for promoter hypermethylation in CRPC specimens compared to benign prostate tissue.
← all excerpts
Methylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapy.
1
—
—